nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—ABCB1—kidney cancer	0.0974	1	CbGaD
Cimetidine—CYP3A7—Temsirolimus—kidney cancer	0.0322	0.0517	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0322	0.0517	CbGbCtD
Cimetidine—ABCB11—Paclitaxel—kidney cancer	0.0314	0.0505	CbGbCtD
Cimetidine—SLC22A5—Dactinomycin—kidney cancer	0.0297	0.0477	CbGbCtD
Cimetidine—SLC22A3—Vincristine—kidney cancer	0.0295	0.0474	CbGbCtD
Cimetidine—ABCB11—Vinblastine—kidney cancer	0.0276	0.0443	CbGbCtD
Cimetidine—ABCB11—Vincristine—kidney cancer	0.0271	0.0435	CbGbCtD
Cimetidine—CYP3A5—Temsirolimus—kidney cancer	0.0241	0.0387	CbGbCtD
Cimetidine—SLC22A2—Vinblastine—kidney cancer	0.0178	0.0285	CbGbCtD
Cimetidine—ABCB11—Doxorubicin—kidney cancer	0.0169	0.0272	CbGbCtD
Cimetidine—ABCB1—Temsirolimus—kidney cancer	0.0157	0.0252	CbGbCtD
Cimetidine—CYP2D6—Temsirolimus—kidney cancer	0.0148	0.0238	CbGbCtD
Cimetidine—CYP3A4—Everolimus—kidney cancer	0.0139	0.0224	CbGbCtD
Cimetidine—CYP2C8—Pazopanib—kidney cancer	0.0122	0.0196	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.011	0.0177	CbGbCtD
Cimetidine—CYP3A7—Paclitaxel—kidney cancer	0.011	0.0177	CbGbCtD
Cimetidine—CYP3A7—Sorafenib—kidney cancer	0.0098	0.0157	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0098	0.0157	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00952	0.0153	CbGbCtD
Cimetidine—CYP3A7—Vincristine—kidney cancer	0.00952	0.0153	CbGbCtD
Cimetidine—CYP1A2—Pazopanib—kidney cancer	0.00943	0.0151	CbGbCtD
Cimetidine—CYP3A4—Temsirolimus—kidney cancer	0.00941	0.0151	CbGbCtD
Cimetidine—CYP3A5—Erlotinib—kidney cancer	0.00905	0.0145	CbGbCtD
Cimetidine—CYP2C9—Capecitabine—kidney cancer	0.00887	0.0142	CbGbCtD
Cimetidine—CYP2C8—Erlotinib—kidney cancer	0.0087	0.014	CbGbCtD
Cimetidine—CYP3A5—Paclitaxel—kidney cancer	0.00828	0.0133	CbGbCtD
Cimetidine—ABCB1—Pazopanib—kidney cancer	0.00825	0.0132	CbGbCtD
Cimetidine—CYP2C8—Paclitaxel—kidney cancer	0.00796	0.0128	CbGbCtD
Cimetidine—CYP3A7—Sunitinib—kidney cancer	0.00794	0.0128	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00794	0.0128	CbGbCtD
Cimetidine—CYP2D6—Pazopanib—kidney cancer	0.00777	0.0125	CbGbCtD
Cimetidine—ABCB1—Dactinomycin—kidney cancer	0.00755	0.0121	CbGbCtD
Cimetidine—CYP3A5—Sorafenib—kidney cancer	0.00735	0.0118	CbGbCtD
Cimetidine—CYP3A5—Vincristine—kidney cancer	0.00714	0.0115	CbGbCtD
Cimetidine—CYP2C8—Sorafenib—kidney cancer	0.00707	0.0114	CbGbCtD
Cimetidine—CYP1A2—Erlotinib—kidney cancer	0.00673	0.0108	CbGbCtD
Cimetidine—ABCB1—Gemcitabine—kidney cancer	0.00596	0.00958	CbGbCtD
Cimetidine—CYP3A5—Sunitinib—kidney cancer	0.00596	0.00957	CbGbCtD
Cimetidine—CYP2C19—Sorafenib—kidney cancer	0.00593	0.00953	CbGbCtD
Cimetidine—ABCB1—Erlotinib—kidney cancer	0.00589	0.00945	CbGbCtD
Cimetidine—CYP2C9—Paclitaxel—kidney cancer	0.00555	0.00892	CbGbCtD
Cimetidine—CYP2D6—Erlotinib—kidney cancer	0.00555	0.00891	CbGbCtD
Cimetidine—CYP1A2—Sorafenib—kidney cancer	0.00547	0.00879	CbGbCtD
Cimetidine—ABCB1—Paclitaxel—kidney cancer	0.00539	0.00865	CbGbCtD
Cimetidine—SLC22A2—nephron—kidney cancer	0.00496	0.0712	CbGeAlD
Cimetidine—CYP3A4—Pazopanib—kidney cancer	0.00494	0.00794	CbGbCtD
Cimetidine—CYP2C9—Sorafenib—kidney cancer	0.00493	0.00792	CbGbCtD
Cimetidine—FMO3—urine—kidney cancer	0.0049	0.0704	CbGeAlD
Cimetidine—ABCB1—Sorafenib—kidney cancer	0.00479	0.00769	CbGbCtD
Cimetidine—ABCB1—Vinblastine—kidney cancer	0.00473	0.00759	CbGbCtD
Cimetidine—ABCB1—Vincristine—kidney cancer	0.00465	0.00746	CbGbCtD
Cimetidine—CYP2D6—Sorafenib—kidney cancer	0.00451	0.00724	CbGbCtD
Cimetidine—CYP2D6—Vinblastine—kidney cancer	0.00445	0.00715	CbGbCtD
Cimetidine—ABCB1—Sunitinib—kidney cancer	0.00388	0.00623	CbGbCtD
Cimetidine—CYP3A4—Erlotinib—kidney cancer	0.00353	0.00566	CbGbCtD
Cimetidine—CYP3A4—Paclitaxel—kidney cancer	0.00323	0.00518	CbGbCtD
Cimetidine—SLC22A8—nephron—kidney cancer	0.00322	0.0462	CbGeAlD
Cimetidine—ABCB1—Doxorubicin—kidney cancer	0.0029	0.00466	CbGbCtD
Cimetidine—CYP3A4—Sorafenib—kidney cancer	0.00287	0.0046	CbGbCtD
Cimetidine—CYP3A4—Vinblastine—kidney cancer	0.00283	0.00455	CbGbCtD
Cimetidine—CYP3A4—Vincristine—kidney cancer	0.00278	0.00447	CbGbCtD
Cimetidine—CYP2D6—Doxorubicin—kidney cancer	0.00274	0.00439	CbGbCtD
Cimetidine—SLC22A8—urine—kidney cancer	0.00258	0.0371	CbGeAlD
Cimetidine—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00241	1	CbGdCrCtD
Cimetidine—CYP3A4—Sunitinib—kidney cancer	0.00232	0.00373	CbGbCtD
Cimetidine—CYP2C19—urine—kidney cancer	0.00217	0.0311	CbGeAlD
Cimetidine—CYP1A2—urine—kidney cancer	0.00177	0.0254	CbGeAlD
Cimetidine—CYP3A4—Doxorubicin—kidney cancer	0.00174	0.00279	CbGbCtD
Cimetidine—CYP2C9—urine—kidney cancer	0.00168	0.0241	CbGeAlD
Cimetidine—CYP2E1—urine—kidney cancer	0.00159	0.0228	CbGeAlD
Cimetidine—FMO1—nephron tubule—kidney cancer	0.00153	0.0219	CbGeAlD
Cimetidine—FMO1—renal system—kidney cancer	0.00139	0.0199	CbGeAlD
Cimetidine—FMO1—kidney—kidney cancer	0.00134	0.0193	CbGeAlD
Cimetidine—FMO1—cortex of kidney—kidney cancer	0.00131	0.0188	CbGeAlD
Cimetidine—CYP3A4—urine—kidney cancer	0.00128	0.0184	CbGeAlD
Cimetidine—CYP2D6—urine—kidney cancer	0.00126	0.0181	CbGeAlD
Cimetidine—SLC22A11—nephron tubule—kidney cancer	0.00123	0.0177	CbGeAlD
Cimetidine—SLC22A6—nephron tubule—kidney cancer	0.00116	0.0167	CbGeAlD
Cimetidine—SLC22A11—renal system—kidney cancer	0.00112	0.0161	CbGeAlD
Cimetidine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00111	0.0159	CbGeAlD
Cimetidine—SLC22A7—renal system—kidney cancer	0.00109	0.0157	CbGeAlD
Cimetidine—SLC22A11—kidney—kidney cancer	0.00108	0.0156	CbGeAlD
Cimetidine—SLC22A2—nephron tubule—kidney cancer	0.00107	0.0154	CbGeAlD
Cimetidine—SLC22A7—kidney—kidney cancer	0.00106	0.0152	CbGeAlD
Cimetidine—SLC22A11—cortex of kidney—kidney cancer	0.00106	0.0151	CbGeAlD
Cimetidine—SLC22A7—cortex of kidney—kidney cancer	0.00103	0.0148	CbGeAlD
Cimetidine—SLC22A6—cortex of kidney—kidney cancer	0.000995	0.0143	CbGeAlD
Cimetidine—SLC22A2—renal system—kidney cancer	0.000974	0.014	CbGeAlD
Cimetidine—HRH2—cardiac atrium—kidney cancer	0.000956	0.0137	CbGeAlD
Cimetidine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00095	0.0136	CbGeAlD
Cimetidine—SLC22A2—kidney—kidney cancer	0.000941	0.0135	CbGeAlD
Cimetidine—SLC22A2—cortex of kidney—kidney cancer	0.000917	0.0132	CbGeAlD
Cimetidine—SLC47A1—nephron tubule—kidney cancer	0.000907	0.013	CbGeAlD
Cimetidine—SLC47A1—renal system—kidney cancer	0.000824	0.0118	CbGeAlD
Cimetidine—SLC47A1—kidney—kidney cancer	0.000797	0.0114	CbGeAlD
Cimetidine—SLC22A4—nephron tubule—kidney cancer	0.000795	0.0114	CbGeAlD
Cimetidine—SLC47A1—cortex of kidney—kidney cancer	0.000776	0.0111	CbGeAlD
Cimetidine—SLC47A1—gonad—kidney cancer	0.000739	0.0106	CbGeAlD
Cimetidine—SLC22A4—renal system—kidney cancer	0.000722	0.0104	CbGeAlD
Cimetidine—SLC22A4—kidney—kidney cancer	0.000698	0.01	CbGeAlD
Cimetidine—SLC22A8—nephron tubule—kidney cancer	0.000696	0.00998	CbGeAlD
Cimetidine—SLC22A1—renal system—kidney cancer	0.000688	0.00987	CbGeAlD
Cimetidine—SLC22A4—cortex of kidney—kidney cancer	0.00068	0.00976	CbGeAlD
Cimetidine—SLC22A1—kidney—kidney cancer	0.000665	0.00954	CbGeAlD
Cimetidine—SLC22A3—renal system—kidney cancer	0.000657	0.00943	CbGeAlD
Cimetidine—SLC22A3—kidney—kidney cancer	0.000636	0.00912	CbGeAlD
Cimetidine—SLC22A8—renal system—kidney cancer	0.000632	0.00908	CbGeAlD
Cimetidine—SLC22A8—kidney—kidney cancer	0.000611	0.00877	CbGeAlD
Cimetidine—SLC22A8—cortex of kidney—kidney cancer	0.000595	0.00854	CbGeAlD
Cimetidine—SLC22A3—gonad—kidney cancer	0.00059	0.00846	CbGeAlD
Cimetidine—SLC22A5—nephron tubule—kidney cancer	0.000526	0.00755	CbGeAlD
Cimetidine—SLC22A5—renal system—kidney cancer	0.000478	0.00686	CbGeAlD
Cimetidine—CYP2C8—renal system—kidney cancer	0.000463	0.00664	CbGeAlD
Cimetidine—SLC22A5—kidney—kidney cancer	0.000462	0.00663	CbGeAlD
Cimetidine—CYP3A5—nephron tubule—kidney cancer	0.00046	0.00659	CbGeAlD
Cimetidine—SLC22A5—cortex of kidney—kidney cancer	0.00045	0.00646	CbGeAlD
Cimetidine—CYP2C8—kidney—kidney cancer	0.000447	0.00642	CbGeAlD
Cimetidine—CYP1A2—renal system—kidney cancer	0.000433	0.00621	CbGeAlD
Cimetidine—CYP2E1—nephron tubule—kidney cancer	0.000429	0.00615	CbGeAlD
Cimetidine—SLC22A5—cardiac atrium—kidney cancer	0.000428	0.00614	CbGeAlD
Cimetidine—CYP3A5—renal system—kidney cancer	0.000418	0.00599	CbGeAlD
Cimetidine—CYP3A5—kidney—kidney cancer	0.000404	0.00579	CbGeAlD
Cimetidine—CYP3A5—cortex of kidney—kidney cancer	0.000393	0.00564	CbGeAlD
Cimetidine—CYP2E1—renal system—kidney cancer	0.00039	0.00559	CbGeAlD
Cimetidine—CYP2E1—kidney—kidney cancer	0.000377	0.0054	CbGeAlD
Cimetidine—CYP2E1—cortex of kidney—kidney cancer	0.000367	0.00526	CbGeAlD
Cimetidine—CYP3A4—renal system—kidney cancer	0.000313	0.0045	CbGeAlD
Cimetidine—CYP2D6—renal system—kidney cancer	0.000308	0.00443	CbGeAlD
Cimetidine—CYP3A4—kidney—kidney cancer	0.000303	0.00435	CbGeAlD
Cimetidine—CYP2D6—kidney—kidney cancer	0.000298	0.00428	CbGeAlD
Cimetidine—Asthenia—Pazopanib—kidney cancer	0.000246	0.00175	CcSEcCtD
Cimetidine—Myalgia—Sorafenib—kidney cancer	0.000245	0.00174	CcSEcCtD
Cimetidine—Arthralgia—Sorafenib—kidney cancer	0.000245	0.00174	CcSEcCtD
Cimetidine—ABCB1—nephron tubule—kidney cancer	0.000244	0.0035	CbGeAlD
Cimetidine—Erythema multiforme—Gemcitabine—kidney cancer	0.000241	0.00171	CcSEcCtD
Cimetidine—Urinary retention—Capecitabine—kidney cancer	0.000241	0.00171	CcSEcCtD
Cimetidine—Somnolence—Everolimus—kidney cancer	0.000241	0.00171	CcSEcCtD
Cimetidine—Dizziness—Temsirolimus—kidney cancer	0.000241	0.00171	CcSEcCtD
Cimetidine—Pneumonia—Paclitaxel—kidney cancer	0.000239	0.0017	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000238	0.00169	CcSEcCtD
Cimetidine—Alopecia—Vincristine—kidney cancer	0.000238	0.00169	CcSEcCtD
Cimetidine—Blood creatinine increased—Capecitabine—kidney cancer	0.000238	0.00169	CcSEcCtD
Cimetidine—Malaise—Dactinomycin—kidney cancer	0.000236	0.00168	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000236	0.00168	CcSEcCtD
Cimetidine—Arthralgia—Sunitinib—kidney cancer	0.000236	0.00167	CcSEcCtD
Cimetidine—Myalgia—Sunitinib—kidney cancer	0.000236	0.00167	CcSEcCtD
Cimetidine—Anaphylactic shock—Sorafenib—kidney cancer	0.000235	0.00167	CcSEcCtD
Cimetidine—Leukopenia—Dactinomycin—kidney cancer	0.000235	0.00167	CcSEcCtD
Cimetidine—Diarrhoea—Pazopanib—kidney cancer	0.000235	0.00166	CcSEcCtD
Cimetidine—Renal failure—Paclitaxel—kidney cancer	0.000234	0.00166	CcSEcCtD
Cimetidine—Fatigue—Everolimus—kidney cancer	0.000233	0.00166	CcSEcCtD
Cimetidine—Constipation—Vinblastine—kidney cancer	0.000232	0.00165	CcSEcCtD
Cimetidine—Atrioventricular block—Doxorubicin—kidney cancer	0.000232	0.00165	CcSEcCtD
Cimetidine—Constipation—Everolimus—kidney cancer	0.000231	0.00164	CcSEcCtD
Cimetidine—Vomiting—Temsirolimus—kidney cancer	0.000231	0.00164	CcSEcCtD
Cimetidine—Thrombocytopenia—Sorafenib—kidney cancer	0.00023	0.00163	CcSEcCtD
Cimetidine—Rash—Temsirolimus—kidney cancer	0.000229	0.00163	CcSEcCtD
Cimetidine—Dermatitis—Temsirolimus—kidney cancer	0.000229	0.00163	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000228	0.00162	CcSEcCtD
Cimetidine—Headache—Temsirolimus—kidney cancer	0.000228	0.00162	CcSEcCtD
Cimetidine—Musculoskeletal pain—Doxorubicin—kidney cancer	0.000228	0.00162	CcSEcCtD
Cimetidine—Dizziness—Pazopanib—kidney cancer	0.000227	0.00161	CcSEcCtD
Cimetidine—Alopecia—Gemcitabine—kidney cancer	0.000226	0.0016	CcSEcCtD
Cimetidine—Fatigue—Erlotinib—kidney cancer	0.000225	0.0016	CcSEcCtD
Cimetidine—Feeling abnormal—Vinblastine—kidney cancer	0.000224	0.00159	CcSEcCtD
Cimetidine—Constipation—Erlotinib—kidney cancer	0.000223	0.00159	CcSEcCtD
Cimetidine—Myalgia—Dactinomycin—kidney cancer	0.000223	0.00158	CcSEcCtD
Cimetidine—Feeling abnormal—Everolimus—kidney cancer	0.000223	0.00158	CcSEcCtD
Cimetidine—ABCB1—renal system—kidney cancer	0.000222	0.00318	CbGeAlD
Cimetidine—Thrombocytopenia—Sunitinib—kidney cancer	0.000221	0.00157	CcSEcCtD
Cimetidine—Vomiting—Pazopanib—kidney cancer	0.000218	0.00155	CcSEcCtD
Cimetidine—Bradycardia—Paclitaxel—kidney cancer	0.000218	0.00154	CcSEcCtD
Cimetidine—Rash—Pazopanib—kidney cancer	0.000216	0.00153	CcSEcCtD
Cimetidine—Nausea—Temsirolimus—kidney cancer	0.000216	0.00153	CcSEcCtD
Cimetidine—Dermatitis—Pazopanib—kidney cancer	0.000216	0.00153	CcSEcCtD
Cimetidine—Agitation—Vincristine—kidney cancer	0.000215	0.00153	CcSEcCtD
Cimetidine—Headache—Pazopanib—kidney cancer	0.000215	0.00152	CcSEcCtD
Cimetidine—ABCB1—kidney—kidney cancer	0.000215	0.00308	CbGeAlD
Cimetidine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000214	0.00152	CcSEcCtD
Cimetidine—Body temperature increased—Everolimus—kidney cancer	0.000214	0.00152	CcSEcCtD
Cimetidine—Aplastic anaemia—Doxorubicin—kidney cancer	0.000211	0.0015	CcSEcCtD
Cimetidine—Leukopenia—Vincristine—kidney cancer	0.00021	0.00149	CcSEcCtD
Cimetidine—Thrombocytopenia—Dactinomycin—kidney cancer	0.00021	0.00149	CcSEcCtD
Cimetidine—ABCB1—cortex of kidney—kidney cancer	0.000209	0.003	CbGeAlD
Cimetidine—Pancytopenia—Capecitabine—kidney cancer	0.000208	0.00148	CcSEcCtD
Cimetidine—Body temperature increased—Erlotinib—kidney cancer	0.000206	0.00147	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000206	0.00146	CcSEcCtD
Cimetidine—Neutropenia—Capecitabine—kidney cancer	0.000205	0.00145	CcSEcCtD
Cimetidine—Nausea—Pazopanib—kidney cancer	0.000204	0.00145	CcSEcCtD
Cimetidine—Fatigue—Sorafenib—kidney cancer	0.000203	0.00144	CcSEcCtD
Cimetidine—Erythema multiforme—Paclitaxel—kidney cancer	0.000202	0.00143	CcSEcCtD
Cimetidine—Constipation—Sorafenib—kidney cancer	0.000201	0.00143	CcSEcCtD
Cimetidine—Malaise—Gemcitabine—kidney cancer	0.0002	0.00142	CcSEcCtD
Cimetidine—Hypersensitivity—Vinblastine—kidney cancer	0.0002	0.00142	CcSEcCtD
Cimetidine—Myalgia—Vincristine—kidney cancer	0.000199	0.00142	CcSEcCtD
Cimetidine—Hypersensitivity—Everolimus—kidney cancer	0.000199	0.00142	CcSEcCtD
Cimetidine—ABCB1—gonad—kidney cancer	0.000199	0.00286	CbGeAlD
Cimetidine—Leukopenia—Gemcitabine—kidney cancer	0.000199	0.00141	CcSEcCtD
Cimetidine—Pneumonia—Capecitabine—kidney cancer	0.000197	0.0014	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000195	0.00138	CcSEcCtD
Cimetidine—Asthenia—Vinblastine—kidney cancer	0.000195	0.00138	CcSEcCtD
Cimetidine—Fatigue—Sunitinib—kidney cancer	0.000195	0.00138	CcSEcCtD
Cimetidine—Asthenia—Everolimus—kidney cancer	0.000194	0.00138	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000194	0.00138	CcSEcCtD
Cimetidine—Constipation—Sunitinib—kidney cancer	0.000193	0.00137	CcSEcCtD
Cimetidine—Renal failure—Capecitabine—kidney cancer	0.000192	0.00136	CcSEcCtD
Cimetidine—Anaphylactic shock—Vincristine—kidney cancer	0.000191	0.00136	CcSEcCtD
Cimetidine—Myalgia—Gemcitabine—kidney cancer	0.000189	0.00134	CcSEcCtD
Cimetidine—Arthralgia—Gemcitabine—kidney cancer	0.000189	0.00134	CcSEcCtD
Cimetidine—Alopecia—Paclitaxel—kidney cancer	0.000189	0.00134	CcSEcCtD
Cimetidine—Asthenia—Erlotinib—kidney cancer	0.000187	0.00133	CcSEcCtD
Cimetidine—Thrombocytopenia—Vincristine—kidney cancer	0.000187	0.00133	CcSEcCtD
Cimetidine—Diarrhoea—Vinblastine—kidney cancer	0.000186	0.00132	CcSEcCtD
Cimetidine—Body temperature increased—Sorafenib—kidney cancer	0.000186	0.00132	CcSEcCtD
Cimetidine—Diarrhoea—Everolimus—kidney cancer	0.000185	0.00131	CcSEcCtD
Cimetidine—Fatigue—Dactinomycin—kidney cancer	0.000184	0.00131	CcSEcCtD
Cimetidine—Flatulence—Paclitaxel—kidney cancer	0.000183	0.0013	CcSEcCtD
Cimetidine—Agranulocytosis—Capecitabine—kidney cancer	0.000182	0.00129	CcSEcCtD
Cimetidine—Hepatic failure—Doxorubicin—kidney cancer	0.000182	0.00129	CcSEcCtD
Cimetidine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000181	0.00129	CcSEcCtD
Cimetidine—Dizziness—Vinblastine—kidney cancer	0.00018	0.00128	CcSEcCtD
Cimetidine—Dizziness—Everolimus—kidney cancer	0.000179	0.00127	CcSEcCtD
Cimetidine—Body temperature increased—Sunitinib—kidney cancer	0.000179	0.00127	CcSEcCtD
Cimetidine—Diarrhoea—Erlotinib—kidney cancer	0.000179	0.00127	CcSEcCtD
Cimetidine—Bradycardia—Capecitabine—kidney cancer	0.000179	0.00127	CcSEcCtD
Cimetidine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000178	0.00126	CcSEcCtD
Cimetidine—Feeling abnormal—Dactinomycin—kidney cancer	0.000176	0.00125	CcSEcCtD
Cimetidine—Hepatitis—Capecitabine—kidney cancer	0.000175	0.00125	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000174	0.00124	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000173	0.00123	CcSEcCtD
Cimetidine—Hypersensitivity—Sorafenib—kidney cancer	0.000173	0.00123	CcSEcCtD
Cimetidine—Vomiting—Vinblastine—kidney cancer	0.000173	0.00123	CcSEcCtD
Cimetidine—Dizziness—Erlotinib—kidney cancer	0.000173	0.00123	CcSEcCtD
Cimetidine—Vomiting—Everolimus—kidney cancer	0.000172	0.00122	CcSEcCtD
Cimetidine—Renal impairment—Doxorubicin—kidney cancer	0.000172	0.00122	CcSEcCtD
Cimetidine—Agitation—Paclitaxel—kidney cancer	0.000171	0.00121	CcSEcCtD
Cimetidine—Rash—Everolimus—kidney cancer	0.000171	0.00121	CcSEcCtD
Cimetidine—Dermatitis—Everolimus—kidney cancer	0.00017	0.00121	CcSEcCtD
Cimetidine—Headache—Vinblastine—kidney cancer	0.00017	0.00121	CcSEcCtD
Cimetidine—Headache—Everolimus—kidney cancer	0.00017	0.0012	CcSEcCtD
Cimetidine—Body temperature increased—Dactinomycin—kidney cancer	0.000169	0.0012	CcSEcCtD
Cimetidine—Asthenia—Sorafenib—kidney cancer	0.000169	0.0012	CcSEcCtD
Cimetidine—Malaise—Paclitaxel—kidney cancer	0.000168	0.00119	CcSEcCtD
Cimetidine—Leukopenia—Paclitaxel—kidney cancer	0.000167	0.00118	CcSEcCtD
Cimetidine—Hypersensitivity—Sunitinib—kidney cancer	0.000167	0.00118	CcSEcCtD
Cimetidine—Vomiting—Erlotinib—kidney cancer	0.000166	0.00118	CcSEcCtD
Cimetidine—Erythema multiforme—Capecitabine—kidney cancer	0.000166	0.00118	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000165	0.00117	CcSEcCtD
Cimetidine—Fatigue—Vincristine—kidney cancer	0.000165	0.00117	CcSEcCtD
Cimetidine—Rash—Erlotinib—kidney cancer	0.000165	0.00117	CcSEcCtD
Cimetidine—Dermatitis—Erlotinib—kidney cancer	0.000164	0.00117	CcSEcCtD
Cimetidine—Headache—Erlotinib—kidney cancer	0.000164	0.00116	CcSEcCtD
Cimetidine—Constipation—Vincristine—kidney cancer	0.000163	0.00116	CcSEcCtD
Cimetidine—Asthenia—Sunitinib—kidney cancer	0.000162	0.00115	CcSEcCtD
Cimetidine—Nausea—Vinblastine—kidney cancer	0.000161	0.00115	CcSEcCtD
Cimetidine—Somnolence—Gemcitabine—kidney cancer	0.000161	0.00114	CcSEcCtD
Cimetidine—Nausea—Everolimus—kidney cancer	0.000161	0.00114	CcSEcCtD
Cimetidine—Diarrhoea—Sorafenib—kidney cancer	0.000161	0.00114	CcSEcCtD
Cimetidine—Arthralgia—Paclitaxel—kidney cancer	0.000158	0.00112	CcSEcCtD
Cimetidine—Myalgia—Paclitaxel—kidney cancer	0.000158	0.00112	CcSEcCtD
Cimetidine—Anxiety—Paclitaxel—kidney cancer	0.000158	0.00112	CcSEcCtD
Cimetidine—Hypersensitivity—Dactinomycin—kidney cancer	0.000158	0.00112	CcSEcCtD
Cimetidine—Fatigue—Gemcitabine—kidney cancer	0.000156	0.00111	CcSEcCtD
Cimetidine—Dizziness—Sorafenib—kidney cancer	0.000155	0.0011	CcSEcCtD
Cimetidine—Constipation—Gemcitabine—kidney cancer	0.000155	0.0011	CcSEcCtD
Cimetidine—Nausea—Erlotinib—kidney cancer	0.000155	0.0011	CcSEcCtD
Cimetidine—Alopecia—Capecitabine—kidney cancer	0.000155	0.0011	CcSEcCtD
Cimetidine—Diarrhoea—Sunitinib—kidney cancer	0.000155	0.0011	CcSEcCtD
Cimetidine—Asthenia—Dactinomycin—kidney cancer	0.000154	0.00109	CcSEcCtD
Cimetidine—Confusional state—Paclitaxel—kidney cancer	0.000153	0.00109	CcSEcCtD
Cimetidine—Blood creatinine increased—Doxorubicin—kidney cancer	0.000153	0.00109	CcSEcCtD
Cimetidine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000152	0.00108	CcSEcCtD
Cimetidine—Body temperature increased—Vincristine—kidney cancer	0.000151	0.00107	CcSEcCtD
Cimetidine—Flatulence—Capecitabine—kidney cancer	0.00015	0.00107	CcSEcCtD
Cimetidine—Dizziness—Sunitinib—kidney cancer	0.000149	0.00106	CcSEcCtD
Cimetidine—Feeling abnormal—Gemcitabine—kidney cancer	0.000149	0.00106	CcSEcCtD
Cimetidine—Vomiting—Sorafenib—kidney cancer	0.000149	0.00106	CcSEcCtD
Cimetidine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000149	0.00106	CcSEcCtD
Cimetidine—Tachycardia—Paclitaxel—kidney cancer	0.000148	0.00105	CcSEcCtD
Cimetidine—Rash—Sorafenib—kidney cancer	0.000148	0.00105	CcSEcCtD
Cimetidine—Dermatitis—Sorafenib—kidney cancer	0.000148	0.00105	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000147	0.00104	CcSEcCtD
Cimetidine—Headache—Sorafenib—kidney cancer	0.000147	0.00104	CcSEcCtD
Cimetidine—Diarrhoea—Dactinomycin—kidney cancer	0.000146	0.00104	CcSEcCtD
Cimetidine—Vomiting—Sunitinib—kidney cancer	0.000144	0.00102	CcSEcCtD
Cimetidine—Body temperature increased—Gemcitabine—kidney cancer	0.000143	0.00102	CcSEcCtD
Cimetidine—Rash—Sunitinib—kidney cancer	0.000143	0.00101	CcSEcCtD
Cimetidine—Dermatitis—Sunitinib—kidney cancer	0.000142	0.00101	CcSEcCtD
Cimetidine—Headache—Sunitinib—kidney cancer	0.000142	0.00101	CcSEcCtD
Cimetidine—Hypersensitivity—Vincristine—kidney cancer	0.000141	0.001	CcSEcCtD
Cimetidine—Nausea—Sorafenib—kidney cancer	0.00014	0.000991	CcSEcCtD
Cimetidine—Pancreatitis—Doxorubicin—kidney cancer	0.000138	0.000983	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000138	0.000982	CcSEcCtD
Cimetidine—Malaise—Capecitabine—kidney cancer	0.000138	0.000978	CcSEcCtD
Cimetidine—Asthenia—Vincristine—kidney cancer	0.000137	0.000974	CcSEcCtD
Cimetidine—Leukopenia—Capecitabine—kidney cancer	0.000137	0.00097	CcSEcCtD
Cimetidine—Vomiting—Dactinomycin—kidney cancer	0.000136	0.000966	CcSEcCtD
Cimetidine—Somnolence—Paclitaxel—kidney cancer	0.000135	0.000958	CcSEcCtD
Cimetidine—Rash—Dactinomycin—kidney cancer	0.000135	0.000958	CcSEcCtD
Cimetidine—Nausea—Sunitinib—kidney cancer	0.000134	0.000953	CcSEcCtD
Cimetidine—Pancytopenia—Doxorubicin—kidney cancer	0.000134	0.000952	CcSEcCtD
Cimetidine—Neutropenia—Doxorubicin—kidney cancer	0.000132	0.000938	CcSEcCtD
Cimetidine—Fatigue—Paclitaxel—kidney cancer	0.000131	0.000929	CcSEcCtD
Cimetidine—Diarrhoea—Vincristine—kidney cancer	0.000131	0.000929	CcSEcCtD
Cimetidine—Asthenia—Gemcitabine—kidney cancer	0.00013	0.000924	CcSEcCtD
Cimetidine—Arthralgia—Capecitabine—kidney cancer	0.00013	0.000923	CcSEcCtD
Cimetidine—Myalgia—Capecitabine—kidney cancer	0.00013	0.000923	CcSEcCtD
Cimetidine—Constipation—Paclitaxel—kidney cancer	0.00013	0.000922	CcSEcCtD
Cimetidine—Anxiety—Capecitabine—kidney cancer	0.00013	0.00092	CcSEcCtD
Cimetidine—Nausea—Dactinomycin—kidney cancer	0.000127	0.000902	CcSEcCtD
Cimetidine—Pneumonia—Doxorubicin—kidney cancer	0.000127	0.000899	CcSEcCtD
Cimetidine—Dizziness—Vincristine—kidney cancer	0.000126	0.000898	CcSEcCtD
Cimetidine—Drowsiness—Doxorubicin—kidney cancer	0.000126	0.000894	CcSEcCtD
Cimetidine—Confusional state—Capecitabine—kidney cancer	0.000126	0.000892	CcSEcCtD
Cimetidine—Feeling abnormal—Paclitaxel—kidney cancer	0.000125	0.000888	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000125	0.000886	CcSEcCtD
Cimetidine—Diarrhoea—Gemcitabine—kidney cancer	0.000124	0.000881	CcSEcCtD
Cimetidine—Renal failure—Doxorubicin—kidney cancer	0.000124	0.000879	CcSEcCtD
Cimetidine—Thrombocytopenia—Capecitabine—kidney cancer	0.000122	0.000866	CcSEcCtD
Cimetidine—Tachycardia—Capecitabine—kidney cancer	0.000122	0.000863	CcSEcCtD
Cimetidine—Vomiting—Vincristine—kidney cancer	0.000122	0.000863	CcSEcCtD
Cimetidine—Rash—Vincristine—kidney cancer	0.000121	0.000856	CcSEcCtD
Cimetidine—Dermatitis—Vincristine—kidney cancer	0.00012	0.000855	CcSEcCtD
Cimetidine—Body temperature increased—Paclitaxel—kidney cancer	0.00012	0.000852	CcSEcCtD
Cimetidine—Headache—Vincristine—kidney cancer	0.00012	0.00085	CcSEcCtD
Cimetidine—Agranulocytosis—Doxorubicin—kidney cancer	0.000118	0.000834	CcSEcCtD
Cimetidine—Vomiting—Gemcitabine—kidney cancer	0.000115	0.000819	CcSEcCtD
Cimetidine—Bradycardia—Doxorubicin—kidney cancer	0.000115	0.000817	CcSEcCtD
Cimetidine—Rash—Gemcitabine—kidney cancer	0.000114	0.000812	CcSEcCtD
Cimetidine—Dermatitis—Gemcitabine—kidney cancer	0.000114	0.000811	CcSEcCtD
Cimetidine—Headache—Gemcitabine—kidney cancer	0.000114	0.000807	CcSEcCtD
Cimetidine—Nausea—Vincristine—kidney cancer	0.000114	0.000806	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000114	0.000806	CcSEcCtD
Cimetidine—Hepatitis—Doxorubicin—kidney cancer	0.000113	0.000803	CcSEcCtD
Cimetidine—Hypersensitivity—Paclitaxel—kidney cancer	0.000112	0.000794	CcSEcCtD
Cimetidine—Asthenia—Paclitaxel—kidney cancer	0.000109	0.000773	CcSEcCtD
Cimetidine—Nausea—Gemcitabine—kidney cancer	0.000108	0.000765	CcSEcCtD
Cimetidine—Fatigue—Capecitabine—kidney cancer	0.000107	0.000763	CcSEcCtD
Cimetidine—Erythema multiforme—Doxorubicin—kidney cancer	0.000107	0.000759	CcSEcCtD
Cimetidine—Constipation—Capecitabine—kidney cancer	0.000107	0.000757	CcSEcCtD
Cimetidine—Diarrhoea—Paclitaxel—kidney cancer	0.000104	0.000738	CcSEcCtD
Cimetidine—Feeling abnormal—Capecitabine—kidney cancer	0.000103	0.000729	CcSEcCtD
Cimetidine—Dizziness—Paclitaxel—kidney cancer	0.0001	0.000713	CcSEcCtD
Cimetidine—Alopecia—Doxorubicin—kidney cancer	9.99e-05	0.000709	CcSEcCtD
Cimetidine—Body temperature increased—Capecitabine—kidney cancer	9.85e-05	0.000699	CcSEcCtD
Cimetidine—Flatulence—Doxorubicin—kidney cancer	9.7e-05	0.000689	CcSEcCtD
Cimetidine—Vomiting—Paclitaxel—kidney cancer	9.66e-05	0.000685	CcSEcCtD
Cimetidine—Rash—Paclitaxel—kidney cancer	9.57e-05	0.00068	CcSEcCtD
Cimetidine—Dermatitis—Paclitaxel—kidney cancer	9.57e-05	0.000679	CcSEcCtD
Cimetidine—Headache—Paclitaxel—kidney cancer	9.51e-05	0.000675	CcSEcCtD
Cimetidine—Hypersensitivity—Capecitabine—kidney cancer	9.18e-05	0.000652	CcSEcCtD
Cimetidine—Agitation—Doxorubicin—kidney cancer	9.05e-05	0.000642	CcSEcCtD
Cimetidine—Nausea—Paclitaxel—kidney cancer	9.02e-05	0.00064	CcSEcCtD
Cimetidine—Asthenia—Capecitabine—kidney cancer	8.94e-05	0.000635	CcSEcCtD
Cimetidine—Malaise—Doxorubicin—kidney cancer	8.88e-05	0.00063	CcSEcCtD
Cimetidine—Leukopenia—Doxorubicin—kidney cancer	8.81e-05	0.000625	CcSEcCtD
Cimetidine—Diarrhoea—Capecitabine—kidney cancer	8.53e-05	0.000605	CcSEcCtD
Cimetidine—Myalgia—Doxorubicin—kidney cancer	8.38e-05	0.000595	CcSEcCtD
Cimetidine—Arthralgia—Doxorubicin—kidney cancer	8.38e-05	0.000595	CcSEcCtD
Cimetidine—Anxiety—Doxorubicin—kidney cancer	8.35e-05	0.000593	CcSEcCtD
Cimetidine—Dizziness—Capecitabine—kidney cancer	8.24e-05	0.000585	CcSEcCtD
Cimetidine—Confusional state—Doxorubicin—kidney cancer	8.1e-05	0.000575	CcSEcCtD
Cimetidine—Anaphylactic shock—Doxorubicin—kidney cancer	8.03e-05	0.00057	CcSEcCtD
Cimetidine—Vomiting—Capecitabine—kidney cancer	7.92e-05	0.000562	CcSEcCtD
Cimetidine—Thrombocytopenia—Doxorubicin—kidney cancer	7.87e-05	0.000558	CcSEcCtD
Cimetidine—Rash—Capecitabine—kidney cancer	7.86e-05	0.000558	CcSEcCtD
Cimetidine—Dermatitis—Capecitabine—kidney cancer	7.85e-05	0.000557	CcSEcCtD
Cimetidine—Tachycardia—Doxorubicin—kidney cancer	7.84e-05	0.000557	CcSEcCtD
Cimetidine—Headache—Capecitabine—kidney cancer	7.81e-05	0.000554	CcSEcCtD
Cimetidine—Nausea—Capecitabine—kidney cancer	7.4e-05	0.000525	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.32e-05	0.00052	CcSEcCtD
Cimetidine—Somnolence—Doxorubicin—kidney cancer	7.14e-05	0.000507	CcSEcCtD
Cimetidine—Fatigue—Doxorubicin—kidney cancer	6.93e-05	0.000492	CcSEcCtD
Cimetidine—Constipation—Doxorubicin—kidney cancer	6.87e-05	0.000488	CcSEcCtD
Cimetidine—Feeling abnormal—Doxorubicin—kidney cancer	6.62e-05	0.00047	CcSEcCtD
Cimetidine—Body temperature increased—Doxorubicin—kidney cancer	6.35e-05	0.000451	CcSEcCtD
Cimetidine—Hypersensitivity—Doxorubicin—kidney cancer	5.92e-05	0.00042	CcSEcCtD
Cimetidine—Asthenia—Doxorubicin—kidney cancer	5.76e-05	0.000409	CcSEcCtD
Cimetidine—Diarrhoea—Doxorubicin—kidney cancer	5.5e-05	0.00039	CcSEcCtD
Cimetidine—Dizziness—Doxorubicin—kidney cancer	5.31e-05	0.000377	CcSEcCtD
Cimetidine—Vomiting—Doxorubicin—kidney cancer	5.11e-05	0.000363	CcSEcCtD
Cimetidine—Rash—Doxorubicin—kidney cancer	5.06e-05	0.00036	CcSEcCtD
Cimetidine—Dermatitis—Doxorubicin—kidney cancer	5.06e-05	0.000359	CcSEcCtD
Cimetidine—Headache—Doxorubicin—kidney cancer	5.03e-05	0.000357	CcSEcCtD
Cimetidine—Nausea—Doxorubicin—kidney cancer	4.77e-05	0.000339	CcSEcCtD
Cimetidine—CYP1A2—Metabolism—PGK1—kidney cancer	7.49e-06	0.000112	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SLC5A3—kidney cancer	7.49e-06	0.000112	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CA9—kidney cancer	7.45e-06	0.000111	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.43e-06	0.000111	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—APC—kidney cancer	7.37e-06	0.00011	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KIT—kidney cancer	7.37e-06	0.00011	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—LDHB—kidney cancer	7.34e-06	0.00011	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GSTP1—kidney cancer	7.31e-06	0.000109	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GSTP1—kidney cancer	7.29e-06	0.000109	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.28e-06	0.000109	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—POMC—kidney cancer	7.24e-06	0.000108	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ITPR2—kidney cancer	7.24e-06	0.000108	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—SCARB1—kidney cancer	7.23e-06	0.000108	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—SCARB1—kidney cancer	7.21e-06	0.000108	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTGS1—kidney cancer	7.15e-06	0.000107	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTGS1—kidney cancer	7.14e-06	0.000107	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—APRT—kidney cancer	7.09e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—FH—kidney cancer	7.09e-06	0.000106	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—MAPK3—kidney cancer	7.06e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PSMD7—kidney cancer	7.02e-06	0.000105	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—POMC—kidney cancer	7.01e-06	0.000105	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PSMD7—kidney cancer	7e-06	0.000105	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CRABP1—kidney cancer	6.95e-06	0.000104	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—BRAF—kidney cancer	6.93e-06	0.000104	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—ABCB1—kidney cancer	6.92e-06	0.000103	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—ABCB1—kidney cancer	6.91e-06	0.000103	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.83e-06	0.000102	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GSTP1—kidney cancer	6.8e-06	0.000102	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CRABP1—kidney cancer	6.78e-06	0.000101	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—MAPK1—kidney cancer	6.72e-06	0.0001	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—GSTM1—kidney cancer	6.71e-06	0.0001	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PTEN—kidney cancer	6.71e-06	0.0001	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—GSTM1—kidney cancer	6.7e-06	0.0001	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.67e-06	9.98e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GPC3—kidney cancer	6.67e-06	9.97e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—BCHE—kidney cancer	6.65e-06	9.95e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—BCHE—kidney cancer	6.64e-06	9.93e-05	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.61e-06	9.88e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ACHE—kidney cancer	6.6e-06	9.87e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GSTT1—kidney cancer	6.6e-06	9.87e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—SLC5A5—kidney cancer	6.57e-06	9.83e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—SLC5A5—kidney cancer	6.56e-06	9.81e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CA2—kidney cancer	6.48e-06	9.7e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ITPR2—kidney cancer	6.46e-06	9.66e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—ABCB1—kidney cancer	6.44e-06	9.63e-05	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—PIK3CA—kidney cancer	6.42e-06	9.6e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CRABP1—kidney cancer	6.39e-06	9.56e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CA9—kidney cancer	6.37e-06	9.52e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CYP1A1—kidney cancer	6.36e-06	9.52e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CYP1A1—kidney cancer	6.35e-06	9.5e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—SLC2A1—kidney cancer	6.35e-06	9.49e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—KRAS—kidney cancer	6.34e-06	9.49e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CRABP1—kidney cancer	6.34e-06	9.48e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.33e-06	9.47e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ALAD—kidney cancer	6.32e-06	9.45e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ITPR2—kidney cancer	6.3e-06	9.43e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—GSTM1—kidney cancer	6.25e-06	9.35e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—SCARB1—kidney cancer	6.25e-06	9.34e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.22e-06	9.31e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTGS1—kidney cancer	6.18e-06	9.25e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.17e-06	9.22e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PSMD7—kidney cancer	6.06e-06	9.07e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.03e-06	9.02e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTGS2—kidney cancer	6.03e-06	9.01e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.95e-06	8.91e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ITPR2—kidney cancer	5.94e-06	8.89e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CYP1A1—kidney cancer	5.92e-06	8.86e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GSTT1—kidney cancer	5.89e-06	8.81e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ACHE—kidney cancer	5.89e-06	8.81e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ITPR2—kidney cancer	5.89e-06	8.81e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—PIK3CA—kidney cancer	5.83e-06	8.72e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RAF1—kidney cancer	5.78e-06	8.65e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PGK1—kidney cancer	5.78e-06	8.64e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.78e-06	8.64e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTGS2—kidney cancer	5.78e-06	8.64e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RELA—kidney cancer	5.76e-06	8.61e-05	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PIK3CA—kidney cancer	5.75e-06	8.6e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GSTT1—kidney cancer	5.75e-06	8.6e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ACHE—kidney cancer	5.75e-06	8.6e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—BCHE—kidney cancer	5.75e-06	8.6e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—ERBB2—kidney cancer	5.72e-06	8.56e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—SLC5A5—kidney cancer	5.68e-06	8.49e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—LDHB—kidney cancer	5.67e-06	8.48e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MTOR—kidney cancer	5.65e-06	8.45e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—SCARB1—kidney cancer	5.58e-06	8.34e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTGS1—kidney cancer	5.52e-06	8.26e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—SLC2A1—kidney cancer	5.48e-06	8.2e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—SCARB1—kidney cancer	5.44e-06	8.14e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.43e-06	8.12e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GSTT1—kidney cancer	5.42e-06	8.1e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ACHE—kidney cancer	5.42e-06	8.1e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CRABP1—kidney cancer	5.41e-06	8.1e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PSMD7—kidney cancer	5.41e-06	8.1e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTGS1—kidney cancer	5.39e-06	8.06e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GSTT1—kidney cancer	5.37e-06	8.03e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ACHE—kidney cancer	5.37e-06	8.03e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.32e-06	7.96e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CDKN1B—kidney cancer	5.3e-06	7.93e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GSTP1—kidney cancer	5.29e-06	7.92e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PSMD7—kidney cancer	5.28e-06	7.9e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GSTP1—kidney cancer	5.28e-06	7.9e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTEN—kidney cancer	5.25e-06	7.86e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL2—kidney cancer	5.19e-06	7.76e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—BCHE—kidney cancer	5.13e-06	7.68e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—SCARB1—kidney cancer	5.13e-06	7.67e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—SCARB1—kidney cancer	5.08e-06	7.6e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTGS1—kidney cancer	5.08e-06	7.59e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—SLC5A5—kidney cancer	5.07e-06	7.58e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCND1—kidney cancer	5.06e-06	7.56e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—JUN—kidney cancer	5.04e-06	7.55e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTEN—kidney cancer	5.04e-06	7.54e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ITPR2—kidney cancer	5.03e-06	7.53e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTGS1—kidney cancer	5.03e-06	7.53e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ABCB1—kidney cancer	5.01e-06	7.49e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—BCHE—kidney cancer	5.01e-06	7.49e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CTNNB1—kidney cancer	5.01e-06	7.49e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ABCB1—kidney cancer	5e-06	7.48e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PSMD7—kidney cancer	4.98e-06	7.45e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—SLC5A5—kidney cancer	4.95e-06	7.4e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PSMD7—kidney cancer	4.94e-06	7.38e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CA9—kidney cancer	4.91e-06	7.35e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.9e-06	7.32e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTEN—kidney cancer	4.88e-06	7.3e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—GSTM1—kidney cancer	4.86e-06	7.27e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—GSTM1—kidney cancer	4.85e-06	7.26e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—SLC2A1—kidney cancer	4.78e-06	7.15e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.75e-06	7.1e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—POMC—kidney cancer	4.75e-06	7.1e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—POMC—kidney cancer	4.74e-06	7.09e-05	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PIK3CA—kidney cancer	4.73e-06	7.08e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—BCHE—kidney cancer	4.72e-06	7.06e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—BCHE—kidney cancer	4.68e-06	7e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.66e-06	6.97e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.64e-06	6.94e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.64e-06	6.94e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.62e-06	6.91e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CYP1A1—kidney cancer	4.61e-06	6.9e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.6e-06	6.88e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GSTT1—kidney cancer	4.59e-06	6.86e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ACHE—kidney cancer	4.59e-06	6.86e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GSTP1—kidney cancer	4.57e-06	6.84e-05	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.56e-06	6.82e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.5e-06	6.73e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.46e-06	6.68e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—POMC—kidney cancer	4.42e-06	6.61e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—VEGFA—kidney cancer	4.41e-06	6.59e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SCARB1—kidney cancer	4.34e-06	6.5e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.33e-06	6.48e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ABCB1—kidney cancer	4.33e-06	6.48e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTGS1—kidney cancer	4.3e-06	6.43e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PSMD7—kidney cancer	4.22e-06	6.31e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GSTM1—kidney cancer	4.2e-06	6.29e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CRABP1—kidney cancer	4.18e-06	6.25e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MAPK3—kidney cancer	4.17e-06	6.24e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.14e-06	6.2e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GSTP1—kidney cancer	4.08e-06	6.11e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MYC—kidney cancer	4.05e-06	6.06e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—BCHE—kidney cancer	4e-06	5.98e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GSTP1—kidney cancer	3.99e-06	5.96e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.98e-06	5.96e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MAPK1—kidney cancer	3.97e-06	5.93e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.95e-06	5.91e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ITPR2—kidney cancer	3.88e-06	5.81e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ABCB1—kidney cancer	3.86e-06	5.78e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.81e-06	5.71e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTGS2—kidney cancer	3.79e-06	5.66e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTGS2—kidney cancer	3.78e-06	5.65e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.78e-06	5.65e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GSTP1—kidney cancer	3.76e-06	5.62e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GSTM1—kidney cancer	3.75e-06	5.61e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KRAS—kidney cancer	3.75e-06	5.6e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GSTP1—kidney cancer	3.72e-06	5.57e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PIK3CA—kidney cancer	3.71e-06	5.54e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.7e-06	5.54e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GSTM1—kidney cancer	3.66e-06	5.48e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.56e-06	5.32e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ABCB1—kidney cancer	3.55e-06	5.32e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PIK3CA—kidney cancer	3.55e-06	5.32e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GSTT1—kidney cancer	3.54e-06	5.3e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ACHE—kidney cancer	3.54e-06	5.3e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ABCB1—kidney cancer	3.52e-06	5.27e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTGS2—kidney cancer	3.52e-06	5.27e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP1A1—kidney cancer	3.47e-06	5.19e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GSTM1—kidney cancer	3.45e-06	5.16e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PIK3CA—kidney cancer	3.44e-06	5.15e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—POMC—kidney cancer	3.44e-06	5.14e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—POMC—kidney cancer	3.43e-06	5.13e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GSTM1—kidney cancer	3.42e-06	5.12e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.35e-06	5.02e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—kidney cancer	3.33e-06	4.98e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.32e-06	4.96e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTEN—kidney cancer	3.3e-06	4.94e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTEN—kidney cancer	3.3e-06	4.93e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.27e-06	4.9e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.27e-06	4.89e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PSMD7—kidney cancer	3.26e-06	4.87e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.24e-06	4.85e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.23e-06	4.83e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GSTP1—kidney cancer	3.18e-06	4.76e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—BCHE—kidney cancer	3.09e-06	4.62e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTEN—kidney cancer	3.07e-06	4.59e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.05e-06	4.56e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ABCB1—kidney cancer	3.01e-06	4.5e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—POMC—kidney cancer	2.97e-06	4.44e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.94e-06	4.4e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GSTM1—kidney cancer	2.92e-06	4.37e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.92e-06	4.37e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.77e-06	4.15e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTGS2—kidney cancer	2.74e-06	4.1e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTGS2—kidney cancer	2.74e-06	4.09e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.66e-06	3.99e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—POMC—kidney cancer	2.65e-06	3.97e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—POMC—kidney cancer	2.59e-06	3.87e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.46e-06	3.67e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—POMC—kidney cancer	2.44e-06	3.65e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—POMC—kidney cancer	2.42e-06	3.62e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTEN—kidney cancer	2.39e-06	3.58e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTEN—kidney cancer	2.39e-06	3.57e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTGS2—kidney cancer	2.37e-06	3.54e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.33e-06	3.48e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CA—kidney cancer	2.33e-06	3.48e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.32e-06	3.48e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.28e-06	3.41e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.26e-06	3.37e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CA—kidney cancer	2.17e-06	3.24e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.14e-06	3.2e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTGS2—kidney cancer	2.12e-06	3.16e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTEN—kidney cancer	2.07e-06	3.09e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—POMC—kidney cancer	2.07e-06	3.09e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTGS2—kidney cancer	2.06e-06	3.09e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.95e-06	2.91e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.93e-06	2.88e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTEN—kidney cancer	1.84e-06	2.76e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTEN—kidney cancer	1.8e-06	2.69e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTEN—kidney cancer	1.7e-06	2.54e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.69e-06	2.52e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.68e-06	2.52e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTEN—kidney cancer	1.68e-06	2.52e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.65e-06	2.47e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—POMC—kidney cancer	1.59e-06	2.39e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.46e-06	2.18e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTEN—kidney cancer	1.44e-06	2.15e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.3e-06	1.95e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.27e-06	1.9e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.27e-06	1.9e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.2e-06	1.79e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.19e-06	1.77e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTEN—kidney cancer	1.11e-06	1.66e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.01e-06	1.52e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.83e-07	1.17e-05	CbGpPWpGaD
